A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer.
Kershaw MH, Westwood JA, Parker LL, Wang G, Eshhar Z, Mavroukakis SA, White DE, Wunderlich JR, Canevari S, Rogers-Freezer L, Chen CC, Yang JC, Rosenberg SA, Hwu P.
Kershaw MH, et al. Among authors: rosenberg sa.
Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6106-15. doi: 10.1158/1078-0432.CCR-06-1183.
Clin Cancer Res. 2006.
PMID: 17062687
Free PMC article.
Clinical Trial.